In a recently updated research report on the global plunger stopper market, FMI has estimated that the industry is set to reach a net worth of USD 143.7 million in FY 2024. The growth of the global plunger stopper industry is driven by the increasing development of prefilled syringes by market players.
The growth of the market is expected to surge at an average of 4.5% over the next decade to arrive at a valuation of USD 223.2 million by the financial year 2034. Key vendors are expected to look out for opportunities in emerging Asian countries as they are showing a higher inclination for the adoption of plunger stoppers, than their developed peers.
| Attributes | Key Insights |
|---|---|
| Plunger Stopper Market Size (2024E) | USD 143.7 million |
| Market Valuation (2034F) | USD 223.2 million |
| Value-based CAGR (2024 to 2034) | 4.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Leading Material Type | Bromobutyl Rubber |
|---|---|
| Value Share (2024) | 39.10% |
The bromobutyl rubber is frequently used to develop plunger stoppers. FMI analysts have estimated this segment is expected to gain hold of a 39.1% share in 2024. Increasing consumer preference for plunger stoppers made of bromobutyl rubber is supporting this segment’s growth.
Bromobutyl rubber is well-suited to be used for applications in pharmaceuticals, due to its outstanding insulation properties, low gas permeability, reduced UV exposure, etc.
| Leading End Use | Pharmaceuticals |
|---|---|
| Value Share (2024) | 43.40% |
The pharmaceutical sector is leading the market space with a share of 43.4% in the year 2024. Surging demand for plunger stoppers due to the increasing prevalence of different infectious and chronic diseases, increasing demand for syringes and other medical products, and the expansion of the healthcare industry are fueling market growth.
Plunger stoppers are extensively used to push out the liquid via the syringe. The plunger stoppers are broadly used in the pharmaceutical sector to dispense liquid. Therefore, the rising use of syringes, prefilled as well as its counterpart is expected to augment sales of plunger stoppers over the forecast period.
Principal Consultant
| Countries | Forecast CAGR (2024 to 2034) |
|---|---|
| The United States | 2.90% |
| Spain | 3.70% |
| China | 5.90% |
| India | 6.70% |
| Thailand | 5.50% |
The plunger stopper industry in the United States is expected to expand at a CAGR of 2.9% over the forecast period.
Key players in the market are offering high-quality and distinct innovative drug delivery solutions to enhance patient well-being. As a result, leading companies like BD (Becton, Dickinson, and Company) are investing in extensive knowledge about combination product development and injection science, to manage complexities and lower risks.
Players are significantly investing in quality and through their extensive manufacturing network, intend to provide security of supply to their customers. Increasing partnerships and new product releases are propelling market growth.
For instance, in October 2021, BD partnered with Aptar Pharma, to launch BD SCF PremiumCoat plunger stopper. It is designed to facilitate the injection of biologics into subcutaneous tissue. The design integrates Aptar Pharma’s cutting-edge formulation and proven film technology to restrict drug component interactions and maintain drug integrity.
Emerging opportunities for players operating in India's plunger stopper industry are raising the market growth at a CAGR of 6.7%. The surging government initiatives, a mounting count of new market entrants, and increasing research and development activities are expected to augment product sales.
Datwyler, which is a Swiss-based industrial supplier of innovative solutions for medical devices and drug packaging, presented its healthcare offering in the historical period. The company has since expanded its manufacturing site in Pune, India. Seeing India as a strong emerging market in the pharma sector, the country holds importance for the company’s future growth.
The company has been focusing on high-end rubber formulations for products like plungers for cartridges, prefilled syringes, serum vials, and Iyo’s stoppers. The company offers an expanded portfolio to meet the evolving requirements in the healthcare market, particularly for the biotech industry.
The plunger stopper market in Thailand is projected to register a CAGR of 5.5% during the assessment period. Local producers in Thailand are leading the global rubber production scene. According to the Thai Latex Association, Thailand significantly contributes to rubber production, making it a prominent producer of rubber worldwide.
Several factors back the market growth. Factors like easy access to raw materials at cheaper prices, supportive government initiatives, increasing export of rubber, and rising consumer spending on pharmaceuticals are some other factors that are fueling market growth.
Thailand, as an exporter of rubber in China, holds an influential share. Since China holds significant production capabilities for plunger stoppers, the import of rubber is positively influencing the stature of Thailand in the plunger stopper market.
The plunger stopper products industry in China is projected to expand at a 5.9% CAGR during the upcoming period. Several factories for syringe plunger stopper products are being set up in the country, fueling the market growth.
China is also a leading exporter of needles for plungers across the globe. The country exports needles for plungers to Peru, India, and the United States.
Increasing production facilities for plunger stoppers in China is fueling the products’ growth. In March 2020, West Pharmaceutical Services Inc., which is a manufacturer of delivery systems and containment for injectable medicines, created a new elastomer formula for its stoppers. The new formula increases the safety and reliability of packaging, transport, and containment phases.
The demand for plunger stoppers in Spain is increasing at a rate of 3.7% through the forecast period. Players in the country are offering plunger stoppers in varied sizes, ensuring that they are compatible with most formats and that their dimensions fit the syringes.
The industries for pharmaceutical and biotechnology are rising in Spain due to increasing application of syringes. Furthermore, the running trend of self-administration of injections is projected to fuel sales of these stoppers.
Key players are developing solutions that meet the patient and healthcare professionals' requirements across therapeutic areas. Industry participants are thus reaching out to biotech and pharmaceutical companies to increase their product sales.
Market players are investing in deep knowledge around injection science, patient experience, and combination product development to manage complexities, anticipate challenges of healthcare staff, and reduce risks.
Contenders are also heavily investing to ensure the quality of their products. They are further ensuring business continuity and security of supply by building a strong global manufacturing network.
Other market penetration strategies for plunger stopper players include mergers and acquisitions and expanding capabilities. Apart from this, they are increasing their facilities to serve the increasing demand from end users.
New Developments in the Global Market
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Current projections of the plunger stopper market indicate a valuation of USD 143.7 million in 2024.
Looking ahead to 2034, the current forecast projects a CAGR of 4.5% for the encasement pipe industry.
FMI predicts the market to reach USD 223.2 million by the year 2034.
Bromobutyl rubber is predicted to hold a significant market share during the forecast period.
India is predicted to offer opportunities for investors and stakeholders.
Daetwyler Holding AG, AptarGroup, Inc., and Gerresheimer AG are powerful players in the plunger stopper industry.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Material 5.1. Chlorobutyl Rubber 5.2. Bromobutyl Rubber 5.3. Silicone 5.4. TPE (Thermoplastic Elastomers) 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Plunger Size 6.1. Less than 1 ML 6.2. 1 ML 6.3. 3 ML 6.4. 5 ML 6.5. 10 ML 6.6. Above 10 ML 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Use 7.1. Pharmaceuticals 7.2. Biotechnology 7.3. Others (Research & Development, etc.) 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. West Pharmaceutical Services, Inc. 18.2. BD (Becton, Dickinson, and Company) 18.3. Dätwyler Holding Inc. 18.4. AptarGroup, Inc. 18.5. Gerresheimer AG 18.6. W. L. Gore & Associates, Inc. 18.7. Shandong Pharmaceutical Glass co., LTD 18.8. Teknor Apex 18.9. Lonstroff AG 18.10. Daikyo Seiko, Ltd. 18.11. Pharmatechs Group LTD 18.12. HEXPOL AB 18.13. Qingdao Huaren Medical Product Co., Ltd. 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Packaging Insights
View Reports
Plunger Stopper Market
